128 related articles for article (PubMed ID: 38876414)
1. Management of Breakthrough Bleeding in Transgender and Gender Diverse Individuals on Testosterone.
Grimstad FW; Boskey ER; Clark RS; Ferrando CA
Am J Obstet Gynecol; 2024 Jun; ():. PubMed ID: 38876414
[TBL] [Abstract][Full Text] [Related]
2. Incidence of breakthrough bleeding in transgender and gender-diverse individuals on long-term testosterone.
Grimstad FW; Boskey ER; Clark RS; Ferrando CA
Am J Obstet Gynecol; 2024 Apr; 230(4):434.e1-434.e10. PubMed ID: 38181830
[TBL] [Abstract][Full Text] [Related]
3. Breakthrough Bleeding in Transgender and Gender Diverse Adolescents and Young Adults on Long-Term Testosterone.
Grimstad F; Kremen J; Shim J; Charlton BM; Boskey ER
J Pediatr Adolesc Gynecol; 2021 Oct; 34(5):706-716. PubMed ID: 33910088
[TBL] [Abstract][Full Text] [Related]
4. Postoperative Vaginal Bleeding Concerns after Gender-Affirming Hysterectomy in Transgender Adolescents and Young Adults on Testosterone.
Cipres DT; Shim JY; Grimstad FW
J Pediatr Adolesc Gynecol; 2023 Feb; 36(1):33-38. PubMed ID: 36089115
[TBL] [Abstract][Full Text] [Related]
5. Retrospective review of changes in testosterone dosing and physiologic parameters in transgender and gender-diverse individuals following hysterectomy with and without oophorectomy.
Grimstad FW; Fraiman E; Garborcauskas G; Ferrando CA
J Sex Med; 2023 Apr; 20(5):690-698. PubMed ID: 36987750
[TBL] [Abstract][Full Text] [Related]
6. Persistent vaginal bleeding during gender-affirming hormone therapy in transgender men.
da Silva ED; Spritzer PM; Fighera TM
J Endocrinol Invest; 2024 Feb; ():. PubMed ID: 38300501
[TBL] [Abstract][Full Text] [Related]
7. Prevalence of pelvic pain in transgender individuals on testosterone.
Grimstad FW; Boskey ER; Clark RS; Ferrando CA
J Sex Med; 2023 Nov; 20(12):1459-1465. PubMed ID: 37837637
[TBL] [Abstract][Full Text] [Related]
8. Early Access to Testosterone Therapy in Transgender and Gender-Diverse Adults Seeking Masculinization: A Randomized Clinical Trial.
Nolan BJ; Zwickl S; Locke P; Zajac JD; Cheung AS
JAMA Netw Open; 2023 Sep; 6(9):e2331919. PubMed ID: 37676662
[TBL] [Abstract][Full Text] [Related]
9. Endometrial findings among transgender and gender nonbinary people using testosterone at the time of gender-affirming hysterectomy.
Hawkins M; Deutsch MB; Obedin-Maliver J; Stark B; Grubman J; Jacoby A; Jacoby VL
Fertil Steril; 2021 May; 115(5):1312-1317. PubMed ID: 33583596
[TBL] [Abstract][Full Text] [Related]
10. The effect of testosterone on ovulatory function in transmasculine individuals.
Taub RL; Ellis SA; Neal-Perry G; Magaret AS; Prager SW; Micks EA
Am J Obstet Gynecol; 2020 Aug; 223(2):229.e1-229.e8. PubMed ID: 32044312
[TBL] [Abstract][Full Text] [Related]
11. Experiences with Menses in Transgender and Gender Nonbinary Adolescents.
Schwartz BI; Effron A; Bear B; Short VL; Eisenberg J; Felleman S; Kazak AE
J Pediatr Adolesc Gynecol; 2022 Aug; 35(4):450-456. PubMed ID: 35123055
[TBL] [Abstract][Full Text] [Related]
12. Functional ovarian reserve in transgender men receiving testosterone therapy: evidence for preserved anti-Müllerian hormone and antral follicle count under prolonged treatment.
Yaish I; Tordjman K; Amir H; Malinger G; Salemnick Y; Shefer G; Serebro M; Azem F; Golani N; Sofer Y; Stern N; Greenman Y
Hum Reprod; 2021 Sep; 36(10):2753-2760. PubMed ID: 34411251
[TBL] [Abstract][Full Text] [Related]
13. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
14. Prescription Patterns and Testosterone Concentrations Achieved With AndroForte 5% Testosterone Cream in Transgender and Gender Diverse Individuals.
Nolan BJ; Zwickl S; Locke P; Simpson S; Li L; Zajac JD; Cheung AS
J Sex Med; 2022 Jun; 19(6):1049-1054. PubMed ID: 35365401
[TBL] [Abstract][Full Text] [Related]
15. Effects of gender-affirming hormone therapy on insulin resistance and body composition in transgender individuals: A systematic review.
Spanos C; Bretherton I; Zajac JD; Cheung AS
World J Diabetes; 2020 Mar; 11(3):66-77. PubMed ID: 32180895
[TBL] [Abstract][Full Text] [Related]
16. Health Outcomes Associated With Having an Oophorectomy Versus Retaining One's Ovaries for Transmasculine and Gender Diverse Individuals Treated With Testosterone Therapy: A Systematic Review.
Kumar S; Mukherjee S; O'Dwyer C; Wassersug R; Bertin E; Mehra N; Dahl M; Genoway K; Kavanagh AG
Sex Med Rev; 2022 Oct; 10(4):636-647. PubMed ID: 35831234
[TBL] [Abstract][Full Text] [Related]
17. Sexual Desire Changes in Transgender Individuals Upon Initiation of Hormone Treatment: Results From the Longitudinal European Network for the Investigation of Gender Incongruence.
Defreyne J; Elaut E; Kreukels B; Fisher AD; Castellini G; Staphorsius A; Den Heijer M; Heylens G; T'Sjoen G
J Sex Med; 2020 Apr; 17(4):812-825. PubMed ID: 32008926
[TBL] [Abstract][Full Text] [Related]
18. Effects of gender affirming hormone treatment in transgender individuals - a retrospective cohort study.
Muir CA; Guttman-Jones M; Man EJ
Endocrine; 2024 Feb; ():. PubMed ID: 38386168
[TBL] [Abstract][Full Text] [Related]
19. Operative Complications, Vaginal Bleeding, and Practice Considerations for Patients on Testosterone Undergoing Gender-Affirming Hysterectomy.
Pando C; Gerlach LR; Challa SA; Pan AY; Francis J
J Minim Invasive Gynecol; 2024 May; ():. PubMed ID: 38823625
[TBL] [Abstract][Full Text] [Related]
20. Hormone Concentrations in Transgender Women Who Self-Prescribe Gender Affirming Hormone Therapy: A Retrospective Study.
Salakphet T; Mattawanon N; Manojai N; Muangmool T; Tangpricha V
J Sex Med; 2022 May; 19(5):864-871. PubMed ID: 35379590
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
